ProQR Therapeutics NV (PRQR)
2.365
-0.06
(-2.67%)
USD |
NASDAQ |
Aug 25, 16:00
2.365
0.00 (0.00%)
After-Hours: 17:35
ProQR Therapeutics Price to Book Value : 3.673 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.774 |
| August 21, 2026 | 3.634 |
| August 20, 2026 | 3.525 |
| August 19, 2026 | 3.448 |
| August 18, 2026 | 3.339 |
| August 17, 2026 | 2.997 |
| August 14, 2026 | 2.982 |
| August 13, 2026 | 2.873 |
| August 12, 2026 | 2.889 |
| August 11, 2026 | 2.982 |
| August 10, 2026 | 2.811 |
| August 07, 2026 | 2.912 |
| August 06, 2026 | 2.951 |
| August 05, 2026 | 3.060 |
| August 04, 2026 | 2.842 |
| August 03, 2026 | 2.656 |
| July 31, 2026 | 2.671 |
| July 30, 2026 | 2.764 |
| July 29, 2026 | 2.687 |
| July 28, 2026 | 2.733 |
| July 27, 2026 | 2.687 |
| July 24, 2026 | 2.671 |
| July 23, 2026 | 2.78 |
| July 22, 2026 | 2.811 |
| July 21, 2026 | 2.920 |
| Date | Value |
|---|---|
| July 20, 2026 | 2.733 |
| July 17, 2026 | 2.640 |
| July 16, 2026 | 2.594 |
| July 15, 2026 | 2.749 |
| July 14, 2026 | 2.640 |
| July 13, 2026 | 2.640 |
| July 10, 2026 | 2.687 |
| July 09, 2026 | 2.733 |
| July 08, 2026 | 2.609 |
| July 07, 2026 | 2.578 |
| July 06, 2026 | 2.671 |
| July 02, 2026 | 2.811 |
| July 01, 2026 | 2.718 |
| June 30, 2026 | 2.889 |
| June 29, 2026 | 4.451 |
| June 26, 2026 | 3.721 |
| June 25, 2026 | 3.806 |
| June 24, 2026 | 4.402 |
| June 23, 2026 | 4.597 |
| June 22, 2026 | 4.572 |
| June 18, 2026 | 4.597 |
| June 17, 2026 | 4.062 |
| June 16, 2026 | 3.697 |
| June 15, 2026 | 3.794 |
| June 12, 2026 | 3.502 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pharming Group NV | 3.293 |
| NewAmsterdam Pharma Co. NV | 5.090 |
| argenx SE | -- |
| Mirum Pharmaceuticals, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 4.029 |
Price to Book Value Related Metrics
| PS Ratio | 11.71 |
| PEG Ratio | -1.114 |
| Price | 2.365 |
| Earnings Yield | -19.61% |
| Market Cap | 333.75M |
| PEGY Ratio | -1.114 |